ATF5 has been identified as a critical regulator in the trade-off between muscle mass and muscle quality during aging. Research conducted on ATF5 knockout (KO) mice reveals that the absence of this transcription factor allows for the retention of muscle mass as the mice age, but at the cost of significantly reduced muscle quality. This finding indicates that while ATF5 is not a viable therapeutic target for preserving muscle mass, it plays a pivotal role in maintaining muscle quality through its regulation of mitochondrial health and function.

The study highlights the importance of mitochondrial quality control (MQC) processes, particularly the Integrated Stress Response (ISR) and the mitochondrial Unfolded Protein Response (UPRmt), which are influenced by ATF5. In aged ATF5 KO mice, there was a notable increase in muscle fatiguability and elevated mitochondrial reactive oxygen species production. Additionally, the expression of ISR/UPRmt transcription factors, such as CHOP and ATF4, was diminished in response to contractile activity, suggesting that ATF5 is crucial for the muscle’s adaptive response to stressors. The findings underscore the role of ATF5 in regulating protein turnover and mitochondrial proteostasis, which are essential for maintaining muscle endurance as organisms age.

This research shifts the paradigm in muscle aging studies by emphasizing the need to explore the mechanisms that differentiate muscle mass retention from quality preservation. Understanding the biochemical pathways surrounding ATF5 may provide insights into novel strategies for enhancing muscle quality without compromising mass, potentially influencing future drug development timelines aimed at mitigating age-related muscle decline.

Source: fightaging.org